Real-time enrollment status for this hypereosinophilic syndrome clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 7:37 AM UTC
| NCT Number | NCT06477653 |
| Recruiting Status | Recruiting |
| Condition | Hypereosinophilic Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT06477653 is currently recruiting participants. This phase2 study for hypereosinophilic syndrome is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06477653 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06477653 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.